Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2019

View Archived Issues

Macrophage-glioma cell interactions can be targeted for PTEN-null glioma

Potential of targeting the miR-21/Wnt/CD44v6 pathway in ovarian cancer

Pharmacological stabilization of TYK2 kinase could treat multiple immune-mediated diseases

Fecal transplants for pancreatic cancer?

High-throughput method for discovering gene interactions

IFN punctures BBB

A neutralizing H7N9 Ab isolated from an infected patient kills infected cells and confers protection

CEPI and PHV enter partnering agreement for development of rVSV-Nipah vaccine candidate

Shanghai Institute of Materia Medica and Suzhou Suplead Life Sciences patent BRD4 inhibitors

New beta-secretase inhibitors synthesized at Novartis

Medshine Discovery presents new antibacterials

New mGluR5 allosteric modulators discovered at Recordati Industria Chimica e Farmaceutica

Kezar Life Sciences initiates PRESIDIO and MARINA phase II studies of KZR-616

DS-39201083 is a new derivative of conolidine with superior analgesic activity

SHR-1653 as a novel highly potent and selective OTR antagonist

Pharmadiall presents new coagulation factor Xa inhibitors

AC Immune partners with University of Pennsylvania to further study TDP-43

CureVac, Yale to jointly discover mRNA-based candidates for pulmonary diseases

DelMar reports updated results from phase II study of VAL-083 in newly diagnosed GBM

Enrollment ongoing in phase III study of tucatinib plus T-DM1 in HER2+ breast cancer

European Commission approves ibrutinib for expanded use in two indications

Too much oxygen may be issue in Leigh syndrome

FDA clears Heat Biologics' IND for study of HS-130 plus HS-110